Want to join the conversation?
Daniel Mannes of Avondale Partners asks about guidance. $MTRX said there is uncertainty in the market and in its ability to book work. There could be impacts on margins and spending patterns. SG&A is not going to be a wide range and tax rate can have a bit of variability depending on mix of work. Volume of revenue and GM will be most impacted.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.